Home › Audentes Therapeutics Acquires Cardiac Gene Therapy Company Cardiogen Sciences
 

Keywords :   


Audentes Therapeutics Acquires Cardiac Gene Therapy Company Cardiogen Sciences

2015-09-02 07:53:29| drugdiscoveryonline News Articles

Audentes Therapeutics, Inc., a biotechnology company committed to the development and commercialization of gene therapy products for patients with serious, rare diseases, recently announced the acquisition of Cardiogen Sciences, Inc., a biotechnology company focused on the discovery and development of adeno-associated virus(AAV) gene therapy products for rare, inherited arrhythmogenic diseases

Tags: company sciences therapy gene

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.11Atlantic Tropical Weather Outlook
06.11Tropical Storm Rafael Graphics
06.11Tropical Storm Rafael Public Advisory Number 9A
06.11Summary for Tropical Storm Rafael (AT3/AL182024)
06.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 9
05.11Tropical Storm Rafael Wind Speed Probabilities Number 9
More »